ADRIANA ARREDONDO: Open Payments
NPI 1174894208 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$611 in 14 payments from 7 companies in 2025. Trend: 2023 $127 · 2024 $319 · 2025 $611
Food & beverage: $611
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $203 |
| Lilly USA, LLC | 4 | $187 |
| Novo Nordisk Inc | 1 | $122 |
| GENZYME CORPORATION | 1 | $30 |
| Abbott Laboratories | 1 | $26 |
| Exact Sciences Corporation | 1 | $23 |
| ABBVIE INC. | 1 | $21 |
Products named: MOUNJARO, AREXVY, Wegovy, SHINGRIX, DUPIXENT, BEXSERO, MITRACLIP, ZEPBOUND.
Industry payments across CA — which companies pay providers there.
